Douglas Kerr Dyne Therapeutics, Inc. (DYN) insider trading activity
Douglas Kerr is Chief Medical Officer of Dyne Therapeutics, Inc.. Currently has a direct ownership of 47,500 shares of DYN, which is worth approximately $1.62 Million. The most recent transaction as insider was on Sep 03, 2024, when has been sold 47,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
47.5K
n/a
3M change
n/a
12M change
Total Value Held
$1.62 Million
Douglas Kerr Transaction History
Also insider at
DK
Douglas Kerr
Chief Medical Officer
Cambridge, MA